Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial.
Carmine G De PasqualeBrian Lee ClaggettKarola S JeringJohn Joseph Valentine McMurrayDouglas L MannZi Michael MiaoChristopher B GrangerLars Valeur KøberAldo Pietro MaggioniJean-Lucien RouleauScott D SolomonPhillippe Gabriel StegPeter Van der MeerEugene BraunwaldMarc A PfefferPublished in: Circulation. Heart failure (2024)
Keyphrases
- acute myocardial infarction
- phase iii
- open label
- phase ii
- healthcare
- palliative care
- percutaneous coronary intervention
- clinical trial
- study protocol
- placebo controlled
- double blind
- quality improvement
- angiotensin converting enzyme
- angiotensin ii
- left ventricular
- pain management
- affordable care act
- acute coronary syndrome
- health insurance